Dr Noam VanderWalde speaks to ecancer at the SIOG 2019 meeting in Geneva about the need for accruing older patients in clinical trials.

He explains that despite the fact that the majority of patients in the clinic are older adults, they are massively underrepresented in clinical trials.

Dr VanderWalde reports, through a study carried out with the Alliance for Clinical Trials in Oncology, that one interesting finding was that as the modalities in trials increase, the more difficult it is to accrue older adults.

This service has been kindly supported by unrestricted grants from Janssen Oncology and Sanofi Genzyme.